YU37113B - Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine - Google Patents

Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Info

Publication number
YU37113B
YU37113B YU3212/79A YU321279A YU37113B YU 37113 B YU37113 B YU 37113B YU 3212/79 A YU3212/79 A YU 3212/79A YU 321279 A YU321279 A YU 321279A YU 37113 B YU37113 B YU 37113B
Authority
YU
Yugoslavia
Prior art keywords
ethylamine
dimethoxy
beta
phenyl
obtaining substituted
Prior art date
Application number
YU3212/79A
Other languages
English (en)
Other versions
YU321279A (en
Inventor
R R Tuttle
J Mills
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU37113(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of YU321279A publication Critical patent/YU321279A/xx
Publication of YU37113B publication Critical patent/YU37113B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU3212/79A 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine YU37113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
YU321279A YU321279A (en) 1983-04-27
YU37113B true YU37113B (en) 1984-08-31

Family

ID=22918877

Family Applications (2)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines
YU3212/79A YU37113B (en) 1972-04-12 1979-12-28 Process for obtaining substituted 3,4-dimethoxy-beta-phenyl-ethylamine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU00976/73A YU36483B (en) 1972-04-12 1973-04-11 Process for obtaining substituted 3,4-dihydroxy-beta-phenetyl amines

Country Status (31)

Country Link
JP (2) JPS5825656B2 (xx)
KR (1) KR790000113B1 (xx)
AR (1) AR203822A1 (xx)
AT (1) AT323719B (xx)
AU (1) AU472734B2 (xx)
BE (1) BE798051A (xx)
BG (1) BG23001A3 (xx)
CA (1) CA1018188A (xx)
CH (2) CH569691A5 (xx)
CS (2) CS190448B2 (xx)
CY (1) CY963A (xx)
DD (1) DD107670B3 (xx)
DE (1) DE2317710C2 (xx)
DK (1) DK142750C (xx)
ES (1) ES413639A1 (xx)
FR (1) FR2182947B1 (xx)
GB (1) GB1392674A (xx)
HK (1) HK50178A (xx)
HU (2) HU167597B (xx)
IE (1) IE37511B1 (xx)
IL (1) IL42016A (xx)
KE (1) KE2870A (xx)
MY (1) MY7800381A (xx)
NL (1) NL174459C (xx)
PH (1) PH11041A (xx)
PL (2) PL90695B1 (xx)
RO (2) RO65105A (xx)
SE (1) SE399064B (xx)
SU (1) SU496719A3 (xx)
YU (2) YU36483B (xx)
ZA (1) ZA732136B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (xx) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
KR840000486A (ko) * 1981-07-22 1984-02-22 원본미기재 치환된 피롤리딘의 제조방법
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
ZA881076B (en) * 1987-02-24 1989-10-25 Lilly Co Eli Dobutamine salts
JPH0383364U (xx) * 1989-12-18 1991-08-23
WO1992020645A1 (fr) * 1991-05-20 1992-11-26 Tsumura & Co. Analogues de phellodendrine et suppresseur d'allergie de type iv les contenant en tant qu'ingredients actifs
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
CA2560922C (en) * 2004-03-26 2014-01-07 New Era Biotech, Ltd. Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
EP2458983B1 (en) 2009-07-31 2015-07-08 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
JP2014524482A (ja) * 2011-08-25 2014-09-22 コグニション セラピューティクス，インコーポレイテッド 神経変性疾患を処置する組成物及び方法
EP4023294A1 (en) 2014-01-31 2022-07-06 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating alzheimer's disease
BR112019023851A2 (pt) 2017-05-15 2020-08-18 Cognition Therapeutics, Inc. compostos, suas composições farmacêuticas e métodos para tratamento de doenças neurodegenerativas
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实（湖南）医药科技有限公司 一种盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
BG23001A3 (xx) 1977-05-20
CY963A (en) 1978-12-22
ES413639A1 (es) 1976-01-16
KE2870A (en) 1978-09-01
CA1018188A (en) 1977-09-27
HU167597B (xx) 1975-11-28
AR203822A1 (es) 1975-10-31
CH569691A5 (xx) 1975-11-28
DK142750B (da) 1981-01-12
IL42016A (en) 1976-05-31
FR2182947A1 (xx) 1973-12-14
BE798051A (fr) 1973-10-11
FR2182947B1 (xx) 1976-07-02
IE37511B1 (en) 1977-08-03
CS190448B2 (en) 1979-05-31
JPS58131945A (ja) 1983-08-06
RO70892A (ro) 1982-02-26
MY7800381A (en) 1978-12-31
SU496719A3 (ru) 1975-12-25
GB1392674A (en) 1975-04-30
DD107670A5 (de) 1974-08-12
JPS497237A (xx) 1974-01-22
ZA732136B (en) 1974-03-27
NL7305097A (xx) 1973-10-16
AU5438573A (en) 1974-10-17
DE2317710C2 (de) 1983-08-04
AT323719B (de) 1975-07-25
AU472734B2 (en) 1976-06-03
PL90695B1 (xx) 1977-01-31
PH11041A (en) 1977-10-25
KR790000113B1 (en) 1979-03-20
JPS6221343B2 (xx) 1987-05-12
HK50178A (en) 1978-09-15
IL42016A0 (en) 1973-06-29
JPS5825656B2 (ja) 1983-05-28
YU97673A (en) 1982-02-25
DE2317710A1 (de) 1973-10-18
CH580563A5 (xx) 1976-10-15
CS190406B2 (en) 1979-05-31
NL174459C (nl) 1984-06-18
DD107670B3 (de) 1988-04-06
NL174459B (nl) 1984-01-16
SE399064B (sv) 1978-01-30
DK142750C (da) 1981-08-17
PL94207B1 (xx) 1977-07-30
RO65105A (ro) 1980-01-15
YU36483B (en) 1984-02-29
HU166213B (xx) 1975-02-28
YU321279A (en) 1983-04-27

Similar Documents

Publication Publication Date Title
YU254979A (en) Process for preparing new 3,4-dihydrocarbostyryl-derivatives
YU321279A (en) Process for obtaining substituted 3,4-dimethoxy-beta-phenetylamines
YU39715B (en) Process for obtaining substituted omega-pentanoprostaglandins
YU34884B (en) Process for preparing 1,2,3-tiadiazole derivatives
YU128373A (en) Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones
YU310573A (en) Process for obtaining 3-hydroxycephalosporins
YU35243B (en) Process for obtaining diphenylyl-alkanoyl-aminopyridines
YU35775B (en) Process for obtaining d-homosteroids
YU40095B (en) Process for obtaining 1,2-dialkyl-3,5-diphenylpirazolium salts
YU36149B (en) Process for obtaining isopropylamines
YU269273A (en) Process for obtaining 2,10-dichloro-12-methyl-12h-dibenzo (d.g.)-(1,3)dioxocines
YU210473A (en) Process for obtaining novel oxo-3-dihydro-2,3-benzoxazine-1,4 derivatives
YU35149B (en) Process for obtaining 15 delta, 16-methylene-4-pregnene
YU229979A (en) Process for obtaining novel 1,4-benzodixane derivatives
YU146973A (en) Process for obtaining oxo-prostaglandins
YU318473A (en) Process for obtaining m-dioxane-5-methylamines
YU49973A (en) Process for obtaining n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine
YU36701B (en) Process for obtaining as-triazinoz5,6-ccquinoline derivatives
YU240180A (en) Process for obtaining deacetoxy-cephalosporin
YU265473A (en) Process for obtaining 7-acylamido-7-alkoxy-cephalosporins
YU35273B (en) Process for obtaining bicyclomycine
CS191448B1 (en) Process for preparing 6,7-dihydrobenztrazole
YU45373A (en) Process for preparing 6,9-dioxo-8-hydroxy-2-(3,4-dihydroxyphenyl)-bicyclo-(3,3,1)-7-nomene-3-01
YU146672A (en) Process for preparing substituted 2-arylaminoimidazolines-(2)
YU15073A (en) Process for preparing new 3,4-dihydrocarbostyryl derivatives